Navigation Links
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies
Date:10/24/2011

SHANGHAI, Oct. 24, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of MedKey Med-Tech Development Co. Ltd. and Jiecheng Med-Tech Development Co. Ltd., two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed.

Founded in 2006, MedKey/Jiecheng have about 80 employees and operate in 15 cities in China, with offices in Shanghai, Beijing, and Guangzhou. The companies provide services in regulatory affairs, Phase I-IV clinical trial management, and clinical trial site management throughout most of the regions in China. Their customer base includes both multinational pharmaceutical companies and domestic Chinese pharmaceutical companies. David Xi, founder, owner, and CEO of the companies, will continue to manage MedKey/Jiecheng as WuXi's Executive Director of Clinical Operations. As part of WuXi, MedKey/Jiecheng will leverage WuXi's broad customer base and will focus on clinical services needed by customers for Chinese regulatory filings and market access.    

"WuXi's acquisition of Medkey/Jiecheng continues our strategy to build an integrated platform of R&D services that will allow anyone and any company to discover and develop drugs more efficiently and cost effectively for patients," said Dr. Ge Li, Chairman and CEO of WuXi. "This acquisition provides WuXi an existing clinical development service capability and infrastructure that WuXi will expand and strengthen to serve our customers' growing clinical development needs in the fast-growing Chinese healthcare market."    

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnolog
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WuXi PharmaTech Announces Second Quarter 2011 Results
2. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
3. WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
4. WuXi PharmaTech Announces First-Quarter 2011 Results
5. WuXi PharmaTech Files 2010 Annual Report on Form 20-F
6. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
7. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
8. WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release
9. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
10. WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
11. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, ... today announced it has completed the sale to Galderma ... Dysport owned or held by Valeant for $1.4 billion ... Nestle S.A, which recently completed its acquisition of Galderma. ... divestiture of our products to a company that is ...
(Date:7/10/2014)... July 10, 2014  Decision Resources Group finds ... disease (ID) specialists are willing to prescribe Durata,s ... for use as OPAT, approximately two-thirds of the ... to their hospital inpatients. However, our findings indicate ... are initiated on OPAT following hospital discharge, and ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... SAN DIEGO, Aug. 26 CareFusion (NYSE: ... announced the national commercial launch of the AVA max® ... during kyphoplasty, a procedure for treating spinal compression fractures. ... represents a competitive breakthrough and is expected to enhance ...
... Inc. (Nasdaq: ALXA ) announced today that ... to Cypress Bioscience, Inc. (Nasdaq: CYPB).  The Staccato ... system designed to help people stop smoking.  The ... a well-validated smoking cessation approach by delivering nicotine via ...
Cached Medicine Technology:CareFusion Announces National Launch of Spinal Fracture Device 2CareFusion Announces National Launch of Spinal Fracture Device 3Alexza's Staccato® Nicotine Licensed to Cypress Bioscience 2Alexza's Staccato® Nicotine Licensed to Cypress Bioscience 3Alexza's Staccato® Nicotine Licensed to Cypress Bioscience 4
(Date:7/11/2014)... 11, 2014 The Europe Well Intervention Market ... Europe with analysis and revenue forecast. The well intervention services ... billion in 2013 to $3.4 billion by 2018, at a ... the TOC of the Europe Well Intervention Market report, to ... provides a glimpse of the segmentation in the Europe well ...
(Date:7/11/2014)... 2014 Operators and owners ... in fuel costs now that model 2019 ... GHG standards are phasing in 2014-2018 ... themselves to install new features into their ... technologies , 2.    Efficient driveline components which reduce ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- U.S. health officials ... were exposed to live anthrax during a safety mishap ... Control and Prevention officials have announced a moratorium on ... high-level government labs. In a report issued Friday, ... to make sure a similar incident doesn,t occur again. ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Alliance ... nation’s only non-profit dedicated exclusively to cell and ... Joshua Corday has joined the organization as Senior ... professional with deep experience securing gifts and addressing ... as Annual Giving Director for NewYork Presbyterian Hospital/Columbia ...
(Date:7/11/2014)... are widely applied in turf and ornamentals. They enhance ... turf and ornamentals in absorption of water, nutrient uptake, ... appear healthy and strong as a result of using ... few years. The most dominating region in biostimulants markets ... share in 2013, and is estimated to grow at ...
Breaking Medicine News(10 mins):Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:CDC Issues Tough Report on Anthrax Scare 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3
... AstraZeneca and the Drugs for Neglected Diseases initiative ... drug-compound screening for leishmaniasis, Chagas disease, and sleeping ... affect nearly 10 million people worldwide. Novel drug ... the drug development pipeline for new medicines urgently ...
... April 11, 2012 -- In a scientific paper published ... from SomaLogic and the University of Washington in Seattle ... technology to tissue samples. Working with both tumor and ... cancer (NSCLC), they identified significant expression changes in 36 ...
... 11 (HealthDay News) -- Holding a gun makes a man appear ... Researchers at the University of California, Los Angeles, asked hundreds ... simply by looking at photos of the men,s hands holding a ... a large saw or a handgun. The hands of the ...
... November 2011, a National Academy of Sciences committee issued ... Maps"-like data network intended to revolutionize medical discovery, diagnosis ... Chancellor Susan Desmond-Hellmann, MD, MPH, is issuing a call-to-arms ... reality. In her editorial, reported in the April ...
... rapidly as California,s population ages, but the majority of state,s ... access to health care and food, a new study from ... Fifty-seven percent of paid Medi-Cal caregivers and ... have incomes that leave them in poverty or near ...
... Denise Mann HealthDay Reporter , WEDNESDAY, April 11 ... disability after a stroke, but they must be given within ... too late to use them. Now, German researchers report ... problem: mobile stroke units. Equipped with what is needed to ...
Cached Medicine News:Health News:AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases 2Health News:SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples 2Health News:People Carrying Guns May Appear Bigger Than They Are 2Health News:UCSF chancellor issues call-to-arms to patient advocates 2Health News:UCSF chancellor issues call-to-arms to patient advocates 3Health News:Majority of California's Medi-Cal caregivers live in or near poverty 2Health News:Majority of California's Medi-Cal caregivers live in or near poverty 3Health News:Mobile Stroke Units Might Trim Time to Treatment 2
The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....
Lose the variability of anaerobic jars and step into the 21st century with the anaerobic workstation that provides the answer to the common problems associated with anaerobic microbiology....
... is the most versatile orthopedic/trauma ... designed for both lower body ... an integrated shoulder attachment. The ... operating table for your most ...
... With MARS, the operating theatre is ready for ... surgical fields. Its modern design allows a quick, ... The individual components are connected securely and sturdily ... system. And if there should ever be a ...
Medicine Products: